Published: March 2012

Publications

Prescriber Update 33(1): 10
March 2012

M² logo

WE NEED YOUR HELP!

Please send your reports for these potential safety issues* listed in the table below.

Medicine Potential safety issue Active monitoring period ends*
Ending soon    
Lansoprazole, pantoprazole Hypomagnesaemia 31 March 2012
     
Extended    
Sildenafil Thromboembolism 30 September 2012
     
New    
Cetirizine Severe mood disorder 30 September 2012
  • M² logo is a Medsafe scheme designed to collect more information on potential safety signals for specific medicines.
  • Safety signals are identified from reports of adverse medicine reactions sent to the Centre for Adverse Reactions Monitoring (CARM). For further information see the Medsafe website.
  • The M² logo scheme does not replace routine adverse reaction reporting. Find out how to report at:  https://nzphvc.otago.ac.nz/report/ or www.medsafe.govt.nz/safety/report-a-problem.asp

CARM logo

www.govt.nz - connecting you to New Zealand central & local government services

Medsafe logo

*The appearance of a possible safety issue in this scheme does not mean Medsafe and CARM have concluded that this medicine causes the reaction.

Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /